mGluR1 길항제로 작용하는 사이에노피리미디논 유도체
    2.
    发明公开
    mGluR1 길항제로 작용하는 사이에노피리미디논 유도체 有权
    三硝基嘧啶衍生物作为MGLUR1拮抗剂

    公开(公告)号:KR1020140101895A

    公开(公告)日:2014-08-21

    申请号:KR1020130014392

    申请日:2013-02-08

    CPC classification number: C07D495/04 A61K31/519

    Abstract: The present invention relates to thienopyrimidinone derivatives as antagonists that act on metabotropic glutamate receptor subtype 1. The thienopyrimidinone derivatives show pharmacological activity against metabotropic glutamate receptor-related diseases, including pain, such as neuropathic pain and migraine, psychiatric diseases, such as anxiety disorder and schizophrenia, urinary incontinence, and neurodegenerative diseases, such as Parkinson′s disease and Alzheimer′s disease. The present invention also relates to methods for preparing the thienopyrimidinone derivatives, and pharmaceutical compositions containing the thienopyrimidinone derivatives as active ingredients.

    Abstract translation: 本发明涉及作为代谢型谷氨酸受体亚型1的拮抗剂的噻吩并嘧啶酮衍生物。噻吩并嘧啶酮衍生物显示针对代谢型谷氨酸受体相关疾病的药理学活性,包括疼痛,如神经性疼痛和偏头痛,精神疾病如焦虑障碍和 精神分裂症,尿失禁和神经变性疾病,如帕金森病和阿尔茨海默病。 本发明还涉及制备噻吩并嘧啶酮衍生物的方法和含有噻吩并嘧啶酮衍生物作为活性成分的药物组合物。

Patent Agency Ranking